ABBV vs RMD
By Alex · Tickerpine
AbbVie Inc. vs ResMed Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | RMD |
|---|---|---|
| Price | $285.64 | $252.86 |
| Market cap | $504.76B | $35.56B |
| P/E ratio | 80.5 | 24.2 |
| ROE | — | 24.27% |
| Profit margin | 9.80% | 26.95% |
| Revenue growth | 10.20% | 8.60% |
| Dividend yield | 2.42% | 1.04% |
| Beta | 0.23 | 0.75 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs RMD in plain English
- ABBV is the bigger company — about 14.2× the market cap of RMD.
- RMD is cheaper on earnings (P/E 24.2 vs 80.5).
- ABBV is growing revenue faster (10% vs 9%).
- ABBV has the higher dividend yield (2.42% vs 1.04%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
RMD return calculator
See what $1,000 in ResMed Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.